Interleukin-9 promotes eosinophilic rejection of mouse heart allografts

Transplantation

Volumn 76, Issue 3, 2003, Pages 572-577

  Poulin, Lionel F ^a   Richard, Mélisande ^b   Le Moine, Alain ^a   Kiss, Robert ^a   McKenzie, Andrew N ^c   Goldman, Michel ^a   Renauld, Jean Christophe ^b   Van Snick, Jacques ^b   Braun, Michel Y ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHILIA; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

ANIMALS; EOSINOPHILIA; EOSINOPHILS; GRAFT REJECTION; HEART TRANSPLANTATION; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-9; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0041465049     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000071201.32424.D2     Document Type: Article

References (30)

1. + T cells in the antitumor immune response. J Exp Med 1998; 188: 2357.
2. + T cells or B cells. J Immunol 1998; 161: 1868.
3. + T cells. J Immunol 1998;161:5236.
4. Le Moine A, Surquin M, Demoor FX, et al. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. J Immunol 1999; 16: 3778.
5. + T lymphocytes and IFN-gamma. Eur J Immunol 2000; 30: 1290
6. Coudert JD, Foucras G, Demur C, et al. Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC class I-T-cell interactions. J Clin Invest 2000; 105: 1125.
7. Telmann UA, Geba GP, Rankin JA, et al. Expression of interleukin-9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998; 188: 1307.
8. McLane MP, Haczku A, van de Rijn M, et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol 1998; 19: 713.
9. Dong Q, Louahed J, Vink A, et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999; 29: 2130.
10. Longphre M, Li D, Gallup M, et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999; 104: 1375.
11. Louahed J, Toda M, Jen J, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000; 22: 649.
12. Richard M, Grencis RK, Humphreys NE, et al. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc Natl Acad Sci U S A 2000; 97: 767.
13. Godfraind C, Louahed J, Faulkner H, et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J Immunol 1998; 160: 3989.
14. Townsend JM, Fallon GP, Matthews JD, et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000; 13: 573.
15. Vink A, Warnier G, Brombacher F, et al. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 1998; 189: 1413.
16. Uyttenhove C, Simpson RJ, Van Snick J. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A 1988; 85: 6934.
17. Sherman MA, Nachman TY, Brown MA. Cutting edge: IL-4 production by mast cells does not require c-mal. J Immunol 1999; 163: 1733.
18. Hultner L, Kolsch S, Stassen M, et al. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 2000; 164: 5556.
19. Fallon PG, Jolin HE, Smith P, et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17: 7.
20. Bennett M. Biology and genetics of hybrid resistance. Adv Immunol 1987; 22: 119.
21. Wang YC, Mayne A, Sell KW, et al. The influence of MHC and non-MHC genes on the nature of cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue. Transplantation 1990; 50: 313.
22. Nagano H, Mitchell RN, Taylor RK, et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997; 100: 550.
23. Marone G, Patella V, de Crescenzo G, et al. Immunological interactions between human eosinophils and cardiac mast cells. Chem Immunol 2000; 76: 118.
24. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med 1993; 44: 85.
25. Gounni AS, Gregory B, Nutku E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival ofhuman eosinophils. Blood 2000; 96: 2163.
26. Teran LM. CCL chemokines and asthma. Immunol Today 2000; 21: 235.
27. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148: 1086.
28. Grohmann U, Van Snick J, Campanile F, et al. IL-9 protects mice from gram-negative bacterial shock: suppression of TNF-α, IL-12, and IFN-γ, and induction of IL-10. J Immunol 2000; 164: 4197.
29. Van Hoffen E, Van Wichen D, Stuij I, et al. In situ expression of cytokines in human heart allografts. Am J Pathol 1996; 149: 1991.
30. Li XC, Schachter AD, Zand MS, et al. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. Transplantation 1998; 66: 265.